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Introduction
Keratins are intermediate fi  lament (IF) proteins that are pref-
erentially expressed in epithelial cells and epidermal append-
ages (Fuchs and Weber, 1994; Coulombe and Omary, 2002). In 
epithelial cells, the prominent IFs include keratins 1–20 (K1–
K20), which are further classifi  ed into type I (K9–K20) and 
II (K1–K8) keratins, which form obligate, noncovalent type 
I/II keratin heteropolymers (Moll et al., 1982; Herrmann and 
Aebi, 2004). Unique keratin complements serve as cell-  specifi  c 
markers that distinguish different epithelial cell types. For ex-
ample, basal epidermal keratinocytes preferentially express K5/
K14, and suprabasal keratinocytes in the upper layer of the skin 
express K1/K10, whereas K8/K18 are the IF proteins of adult 
hepatocytes (Moll et al., 1982; Coulombe and Omary, 2002). 
K8/K18 is also the prototype keratin pair of simple-type epi-
thelia and, as such, is broadly expressed in epithelial compo-
nents of glandular tissues, including the pancreas and intestine, 
with variable levels of K19, K20, and K7, depending on the 
cell type (Ku et al., 1999). All IF proteins, including keratins, 
contain a central and conserved coiled coil–forming α-helical 
“rod” domain that is fl  anked by relatively nonconserved non–
α-helical NH2-terminal “head” and COOH-terminal “tail” do-
mains (Fuchs and Weber, 1994; Herrmann and Aebi, 2004). 
The fl  anking head and tail domains are the more exposed por-
tions of IF proteins, which explains why all IF phosphorylation 
sites reside in these domains (Omary et al., 1998). Several in 
vivo K8/K18 phosphorylation sites have been identifi  ed that 
include K8 Ser23/Ser73/Ser431 and K18 Ser33/Ser52 (Omary 
et al., 1998). K8/K18 hyperphosphorylation correlates with dis-
ease progression in patients with chronic liver disease (Toivola 
et al., 2004; Zatloukal et al., 2004) and plays an essential role in 
regulating keratin fi  lament organization, association with bind-
ing partners such as 14-3-3 proteins, and turnover (Coulombe 
and Omary, 2002).
Keratin mutations are associated with several skin, oral, 
esophageal, ocular, hair, and liver diseases that refl  ect  the 
 tissue-specifi  c expression of the particular keratin (Fuchs and 
  Cleveland, 1998; Omary et al., 2004). The resulting disease-
related tissue defects are manifestations of the clearly defi  ned 
function of keratins that allows cells to cope with mechanical 
stresses. This keratin-related cytoprotective effect is most evident 
in the keratinocyte fragility phenotype of human epidermolysis 
bullosa simplex (EBS), which is caused by K5/K14 mutations, 
and is evident in the phenotypes of several animal models that 
lack or express mutant keratins (Fuchs and   Cleveland, 1998; 
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eratin 8 (K8) variants predispose to human liver in-
jury via poorly understood mechanisms. We gen-
erated transgenic mice that overexpress the human 
disease-associated K8 Gly61-to-Cys (G61C) variant and 
showed that G61C predisposes to liver injury and apop-
tosis and dramatically inhibits K8 phosphorylation at ser-
ine 73 (S73) via stress-activated kinases. This led us to 
generate mice that overexpress K8 S73-to-Ala (S73A), 
which mimicked the susceptibility of K8 G61C mice to 
  injury, thereby providing a molecular link between K8 
phosphorylation and disease-associated mutation. Upon 
apoptotic stimulation, G61C and S73A hepatocytes have 
persistent and increased nonkeratin proapoptotic sub-
strate phosphorylation by stress-activated kinases, com-
pared with wild-type hepatocytes, in association with an 
inability to phosphorylate K8 S73. Our ﬁ  ndings provide 
the ﬁ  rst direct link between patient-related human keratin 
variants and liver disease predisposition. The highly abun-
dant cytoskeletal protein K8, and possibly other keratins 
with the conserved S73-containing phosphoepitope, 
can protect tissue from injury by serving as a phos-
phate “sponge” for stress-activated kinases and thereby 
provide a novel nonmechanical function for intermediate 
ﬁ  lament proteins.
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  Magin et al., 2004; Omary et al., 2004). Emerging evidence 
also   indicates that keratins protect cells from nonmechanical 
injury via mechanisms that include keratin regulation of cell 
signaling cascades, regulation of susceptibility to apoptosis, 
and modulation of protein targeting to subcellular compart-
ments (  Coulombe and Omary, 2002; Toivola et al., 2005). For 
example, livers of K8- or K18-null mice or mice that express 
K18 Arg89-to-Cys (an EBS-like mutation) manifest a remark-
able predisposition to injury and apoptosis (Ku et al., 1996, 
2003; Loranger et al., 1997; Caulin et al., 2000; Gilbert et al., 
2001). K18 R89C and K14 R125 residues and their surround-
ing amino acids are highly conserved, and K14 R125 muta-
tions cause the severest form of EBS and are the most common 
in keratin-related skin diseases (Fuchs and Cleveland, 1998; 
  Porter and Lane, 2003).
Most human keratin-associated diseases are caused by 
  autosomal-dominant keratin missense mutations with near 
  complete penetrance, and most of these mutations are located at 
highly conserved regions at the ends of the rod domain (Porter 
and Lane, 2003; Omary et al., 2004). Exceptions include muta-
tions in K8/K18, which pose a risk for the subsequent develop-
ment of cirrhosis and liver disease progression (Ku et al., 1997, 
2001, 2005; Strnad et al., 2006a,b), and may also be associated 
with infl  ammatory bowel disease (Owens et al., 2004). All known 
human K8/K18 mutations do not involve the highly conserved 
ends of the rod domain. For example, the EBS-like K18 Arg89-
to-Cys mutation, which causes hepatocyte fragility and predis-
poses to hepatocyte injury and apoptosis in mice (Ku et al., 1995, 
1996, 2003), has not been found in humans, and it is hypothe-
sized that such mutations are embryolethal (Omary et al., 2002; 
Porter and Lane, 2003). The prevalence odds ratio for the associ-
ation of K8/K18 mutations with human cirrhosis is 3.8 (95% 
confi  dence interval of 2.1–7.1), and the association with liver 
disease is highly signifi  cant when comparing a large American 
cohort of liver disease patients who underwent liver transplanta-
tion with a control group (P < 0.0001; Ku et al., 2005). In addi-
tion, a study using a large German patient cohort with chronic 
hepatitis C showed a signifi  cant association of exonic K8 vari-
ants with increased fi  brosis (Strnad et al., 2006a).   However, di-
rect evidence for the predisposition to liver injury via any natural 
human K8/K18 mutation has not been described.
To address the in vivo signifi  cance of human liver  disease–
associated keratin mutations, we generated transgenic mice that 
overexpress wild-type (WT) or Gly61-to-Cys (G61C) human 
K8 (hK8) and compared their susceptibility to stress-induced 
liver injury. We targeted K8 G61 for the following reasons: (a) 
K8 G61 is highly conserved among type II keratins (Fig. 1 A), 
(b) K8 G61C is the second most prevalent among K8/K18 vari-
ants that are associated with cirrhosis and fi  brosis progression 
(Ku et al., 2005; Strnad et al., 2006a), and (c) in transfected 
cells, G61C interferes with keratin fi  lament reorganization and 
cross-links hK8 under oxidative conditions (Ku et al., 2001, 
2005). The G61C mice unmasked an important relationship 
  between K8 G61C mutation and K8 S73 phosphorylation by 
stress-activated protein kinases (SAPKs). This relationship was 
further explored by generating transgenic mice that overexpress 
K8 S73A.
Results
K8 G61C predisposes to stress-induced 
liver injury in transgenic mice
Transgene expression of the WT and G61C K8 mice was con-
fi  rmed by blotting total liver homogenates with antibodies (Abs) 
specifi  c to hK8, and by Coomassie staining of a cytoskeletal 
high salt extract (HSE) that shows the total liver keratin compo-
sition and distinguishes endogenous from exogenous keratins 
(Fig. 1 B). Importantly, protein levels of the endogenous mouse 
WT K8 and human G61C transgene product are similar, which 
mimics what is seen in human liver disease patients with hetero-
zygous K8 G61C expression. Cross-linked hK8 is found only in 
G61C, but not WT, livers (Fig. 1 B) because of the absence of 
Cys in WT hK8. Both WT and G61C mice were viable, fertile, 
and had no obvious phenotype under basal conditions.  Previously 
described transgenic mice that overexpress high levels of WT 
K8, using the same WT hK8 we used, also do not have liver ab-
normalities under basal conditions, but develop pancreatic in-
suffi  ciency that is possibly related to the WT hK8 expression 
level (Casanova et al., 1999). The K8 WT and G61C mice de-
scribed herein do not have abnormal histology in their pancreata 
under basal conditions (unpublished data).
We tested the consequence of G61C on susceptibility to 
liver injury using the Fas (which causes hepatocyte apoptosis; 
Ku et al., 2003) or microcystin-LR (MLR; which causes hemor-
rhagic hepatitis; Ku et al., 1998) injury models. Fas or MLR ad-
ministration causes signifi  cant lethality (Fig. 1, C and D), and 
the G61C mice were markedly more susceptible to lethal liver 
injury as compared with nontransgenic and hK8 WT mice 
( 80% G61C vs.  40% control; Fig. 1 E). The increased le-
thality of G61C, as compared with WT mice, is caused by se-
vere liver hemorrhage and apoptosis (Fig. 2 A). Although K8 
G61C forms normal-appearing keratin fi  laments under basal 
conditions, Fas administration causes hepatocyte drop-off and a 
more prominent keratin fi  lament collapse in G61C, as compared 
with WT mice (Fig. 2 B). Fas administration also modulates 
K8/K18 phosphorylation (Ku et al., 2003), including an increase 
in K8 S73/S431 and a decrease in K18 S33 phosphorylation in 
all transgenic lines (Fig. 2 C). However, K8 S73 hyperphos-
phorylation (Fig. 2 C) was signifi  cantly less in G61C, as com-
pared with WT livers (65% less, as determined using quantitative 
blotting with anti-K8 pS73 Ab; not depicted). The increased 
apoptosis in K8 G61C-expressing hepatocytes was also con-
fi  rmed by enhanced formation of the caspase-generated K18 
fragment (Fig. 2 C). Therefore, the natural K8 G61C mutation 
causes a dramatic increase in transgenic mouse susceptibility to 
stress-induced liver injury.
Comparison of the effect of K8 and K18 
mutation, or absence, in transfected cells 
and mouse livers
We compared the effect of K8 G61C (i.e., the patient-related 
variant) and K18 R89C mutation, or K8/K18 absence in trans-
fected cells and mouse livers. K18 R89C is not a natural muta-
tion, but K18 R89 is highly conserved among all IF proteins and 
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keratin-related diseases such as EBS (Porter and Lane, 2003). 
Overexpression of K18 R89C in transgenic mice causes hepato-
cyte keratin fi  lament disruption, hepatocyte fragility, and en-
hanced susceptibility to liver injury and apoptosis (Ku et al., 
1995, 2003) and was the major clue that led us to search for, and 
then associate, K8/K18 variants with human liver disease (Ku 
et al., 1997). When tested in transfected cells, K8 G61C be-
haves similarly to K18 R89C (a control for Cys mutation); both 
are highly insoluble and generate keratin cross-links upon oxi-
dative challenge when compared with WT K8 and another natu-
ral K8 (R340H) variant (Fig. 3 A). The cross-linked K8 species 
are clearly detected in total lysates, but not cytosol (Fig. 3 A, 
lane 11 vs. 15), which indicates that most of these species are in 
the fi  lament fraction. K8 G61C insolubility (Fig. 3 B) and cross-
linking after Fas or paraquat administration (Fig. 3 C) were 
similarly noted in transgenic mouse livers.
We then assessed hepatocyte fragility and the expression 
of several apoptosis-related proteins in K8 G61C mice as 
compared with K18 R89C, K8-, and K18-null mice. The K8- 
or K18-null mice, and K18 R89C mice, have a dramatically 
increased susceptibility to liver injury and apoptosis (Marceau 
et al., 2001; Omary et al., 2002; Zatloukal et al., 2004). We 
examined the expression of several apoptosis-associated pro-
teins because c-Flip protein, but not mRNA, was reported to 
be absent in K8-null mouse liver, and c-Flip absence may 
  account for the increased susceptibility of K8-null livers to 
apoptosis (Gilbert et al., 2004). We did not observe any differ-
ence in c-Flip (using two independent anti–c-Flip Abs) or sev-
eral other apoptosis-associated protein levels between these 
four mouse groups and nontransgenic mouse groups (Fig. 3 D), 
which indicates that the previously reported results with 
c-Flip (Gilbert et al., 2004) were likely caused by differences 
in Ab specifi  city.
We then examined hepatocyte fragility in K18-null, K8 
WT, and K8 G61C mice upon liver perfusion because K8-null 
and the EBS-like K18 R89C livers have remarkably fragile 
Figure 1.  hK8 G61C mice have increased 
susceptibility to liver injury. (A) Alignment of 
the hK8 sequence that is proximal to G61 
(shaded residue) with other type II keratins. m, 
mouse; r, rat; and f, frog. Single letter abbrevi-
ations are used for amino acids, and bold dots 
indicate amino acids that are identical to hK8. 
(B) Livers were isolated from nontransgenic 
(lane 1) or transgenic mice that overexpress 
hK8 WT (lanes 2 and 3) or G61C (lanes 4 
and 5). Two independent transgenic lines per 
genotype were used (i.e., each lane from 2 to 
5 represents one mouse per transgenic line). 
Livers were homogenized, followed by HSE to 
purify the total keratin pool, or were solubi-
lized in 2% SDS-containing sample buffer to 
obtain total lysates (Ku et al., 2004). Isolates 
were separated by SDS-PAGE, and then visual-
ized by Coomassie staining (HSE prepara-
tions) or by immunoblotting (total liver 
homogenates) with Abs to m/hK8, hK8, and 
mK18. Cross-linked K8 is detected only in liv-
ers from K8 G61C mice, and disappears if 
samples are analyzed under reducing condi-
tions (not depicted). (C and D) The following 
three mouse genotypes were used: nontrans-
genic FVB/n, transgenic hK8 WT, or G61C 
mutant mice (16–32 age- and sex-matched 
mice per genotype). Each analyzed genotype 
consisted of nearly equal portions of the two 
generated independent lines (WT
1 and WT
2; 
G61C
1 and G61C
2). After Fas (C) or MLR (D) 
injection, mice were assessed hourly for 12 h, 
and then every 10 h for 3 d. The analyses 
show survival curves for each administered 
agent. (E) Summary of the mouse lethality data 
shown in C and D. No signiﬁ  cant difference 
in mortality was observed when comparing 
FVB/n with hK8 WT mice, whereas mortality 
was markedly increased in hK8 G61C mice as 
compared with the combined FVB/n + hK8 
WT mice.JCB • VOLUME 174 • NUMBER 1 • 2006  118
  hepatocytes (Ku et al., 1995; Loranger et al., 1997). Nontrans-
genic and K18 R89C mice were used as controls. Hepatocytes 
isolated from nontransgenic, K8 WT, and K8 G61C livers had 
82–89% (n = 4–6 livers/genotype) viability as compared with 
hepatocytes from K18-null livers, which had only 16–22% via-
bility (n = 3). Hence, the phenotypes of keratin-null or keratin 
mutant genotypes (summarized in Fig. 3 E) suggest that K8 
G61C alters hepatocyte function differently than when K18 is 
mutated at R89C or K8/K18 proteins are absent. This is despite 
the fi  nding that both K18 R89C and K8 G61C decrease keratin 
solubility and cause cross-linking during oxidative conditions 
(Fig. 3, A–C).
K8 G61C disrupts K8 S73 phosphorylation 
by stress-activated kinases
Human K8 includes three major in vivo phosphorylation sites 
(S23/S73/S431) that are conserved in mouse K8 (Omary et al., 
1998). S23 is phosphorylated under basal conditions, and S73/
S431 are phosphorylated by SAPKs, such as p38, JNK, and p42 
MAPK. p38 phosphorylates only S73 and generates a unique, 
slightly slower-migrating K8 species (termed HK8) upon SDS-
PAGE, whereas JNK and p42 phosphorylate S73/S431 and gen-
erate both HK8 and K8 phosphospecies (Fig. 4 A; He et al., 
2002; Ku et al., 2002). Given that the natural hK8 G433S alters 
K8 S431 in vitro phosphorylation by p42 MAPK (Fig. 4 A; 
Figure 2.  K8 G61C accentuates Fas-induced liver injury. Livers were obtained from the indicated transgenic mice 4 h after PBS or Fas Ab administration. 
(A) Histological analysis (a–d) and TUNEL assay (a’–d’) of transgenic mouse livers that were isolated after PBS (−) or Fas (+) intraperitoneal injection. Note 
the severe hemorrhage (H) and pyknotic nuclei in hK8 G61C (d and d’) as compared with hK8 WT liver (b and b’) after Fas administration. (B) Immunoﬂ  uo-
rescence staining of livers similar to those shown in A using an Ab that is speciﬁ  c to hK8. Note the similar staining pattern of hK8 WT and G61C livers un-
der basal conditions (a and c), but the marked hepatocyte drop-off and the collapse of keratin ﬁ  laments in G61C livers compared with WT mice after Fas 
injection (b and d). (C) Mouse livers were homogenized, followed by isolation of the total keratin pool by HSE. The extracts were separated by SDS-PAGE, 
and then visualized by Coomassie staining or blotting with Abs to the indicated epitopes. Each lane represents the analysis of one independent mouse liver. 
Bars: (A) 160 μm; (B) 40 μm.KERATINS AS A PHOSPHATE SPONGE • KU AND OMARY 119
Ku et al., 2005; likely caused by proximity), we tested the ef-
fect of several K8 mutations on K8 phosphorylation by p38/
JNK/p42. K8 G61C blocks S73 phosphorylation by purifi  ed 
SAPKs, but does not completely eliminate S73 in vivo phos-
phorylation (likely via other kinases), as determined by blot-
ting of transfected-cell total lysates (Fig. 4 B) or transgenic 
mouse livers (Fig. 2 C) with anti-K8 pS73–specifi  c Ab. Some 
of the other K8 mutants also inhibited K8 phosphorylation 
(R453C [all three kinases] and G433S [p42]), but the most 
prominent effect was noted in G61C (Fig. 4 B). Moreover, K8 
I62V, which is a variant found at higher frequency in controls 
as compared with liver disease patients (Ku et al., 2005), has 
similar S73 in vitro phosphorylation by the SAPKs as WT K8 
(unpublished data). We further substantiated the effect of K8 
G61C by comparing K8 S73 phosphorylation in BHK cells co-
transfected with WT or kinase-inactive p38. K8 G61C causes 
the near-complete absence of K8 S73 phosphorylation by trans-
fected p38, which is similar to the near-absent phosphorylation 
of WT K8 upon kinase-inactive p38 transfection (Fig. 4 C). 
Hence, K8 G61C signifi  cantly inhibits K8 S73 phosphoryla-
tion in vivo by SAPKs.
K8 S73A predisposes to Fas-induced liver 
injury in transgenic mice
The effect of K8 G61C on S73 phosphorylation led us to hy-
pothesize that the inability to phosphorylate S73 in K8 G61C 
mice is a major trigger for their increased susceptibility to 
  apoptosis. We tested this hypothesis by generating transgenic 
mice that overexpress hK8 S73A and tested their predisposition 
to apoptosis. Expression of hK8 S73A was verifi  ed by blotting 
using anti-hK8–specifi  c Ab and by detection of K8 S73 phos-
phorylation, after Fas administration, in WT but not S73A hK8 
livers (Fig. 5 A). Fas administration increases K8 S431 phosphor-
ylation in WT and S73A, but generates the K18 apoptotic 
Figure 3.  K8 G61C decreases keratin solubility and promotes keratin cross-linking without altering hepatocyte fragility. (A) BHK cells were transiently co-
transfected with the indicated mutant and/or WT keratins (K8 WT + K18 WT; K8 WT + K18 R89C; K18 WT + K8 G61C or R340H). After 3 d, cells 
were cultured in the presence or absence of 20 mM H2O2 for 1 h, and then divided into two portions. One portion was used to isolate a detergent-free cy-
tosolic soluble fraction and the second to generate a total cell lysate. The isolates were subjected to SDS-PAGE under nonreducing conditions (to visualize 
cross-linked K8) and blotted with Abs speciﬁ  c to hK8 or hK18. Coomassie staining is also shown to demonstrate equal gel loading. Arrow indicates de-
graded K8. (B) Liver perfusion was used to isolate hepatocytes from hK8 WT and G61C mice. Total lysates and detergent-free cytosolic fractions were pre-
pared from the isolated hepatocytes, followed by blotting with Abs speciﬁ  c to hK8, m/hK18, and mK18. Open arrows indicate degraded K8. (C) Oxidative 
stress or apoptosis was induced in mice by intraperitoneal administration of paraquat or Fas Ab, respectively. Total liver lysates were isolated and blotted 
with anti-hK8 Ab. Asterisk indicates nonspeciﬁ  c bands. Each lane represents the analysis of one independent mouse liver. (D) Total homogenates were pre-
pared from livers of the indicated mouse genotypes (2 mice/genotype), followed by SDS-PAGE and blotting with Abs to the indicated proteins. A duplicate 
gel was stained with Coomassie blue to verify equal protein loading. Note that the K8 and K18 proteins are absent in both K8- and K18-null livers (lanes 
3–6) because of degradation of the partner protein (Baribault et al., 1994; Magin et al., 1998). (E) Liver perfusion of K18-null, K18 R89C, K8 WT, and 
K8 G61C was performed to assess hepatocyte fragility. K18 R89C was used as a control and hepatocytes from these mice are already known to be fragile 
(Ku et al., 1995). Hepatocytes from K18-null and hK18 R89C livers had 16–24% viability (n = 3–6 livers/genotype), whereas hK8 WT and G61C hepa-
tocytes had 82–89% viability (n = 4–6 livers/genotype). A summary of the phenotypes of transgenic mice that lack keratin expression (K8- and K18-null) 
or that express mutant K8 or K18 is shown. Shaded parameters are those examined in this study, whereas unshaded parameters represent summaries of 
previous studies (Marceau et al., 2001; Omary et al., 2002; Zatloukal et al., 2004).JCB • VOLUME 174 • NUMBER 1 • 2006  120
  fragment more prominently in S73A livers (Fig. 5 A). This sug-
gests that inhibition of K8 S73 phosphorylation increases 
  susceptibility to Fas-mediated liver injury, which was con-
fi  rmed by the marked lethality of S73A, as compared with WT 
K8 and nontransgenic mice (Fig. 5, B and C). The increased le-
thality of K8 S73A mice is likely attributable to increased hem-
orrhage and apoptosis (Fig. 5 D), which mimics fi  ndings in K8 
G61C mice (Fig. 2 A). K8 S73A and G61C mice share other 
features, including normal-appearing keratin fi  laments under 
basal conditions (Fig. 5 D), and similar cell viability of the 
  isolated hepatocytes after liver perfusion (84–92% viability; 
n = 5 livers).
K8 G61C or S73A lead to sustained 
and enhanced phosphorylation of SAPK 
substrates after Fas-induced apoptosis
We hypothesized that G61C or S73A expression shunts phos-
phorylation from K8 S73 to other SAPK substrates after Fas 
stimulation. This hypothesis is based on the following: (a) cel-
lular abundance of K8 (e.g., prominent Coomassie staining; 
Fig. 1 B), (b) its role as an in vivo substrate for SAPKs (He 
et al., 2002; Ku et al., 2002), (c) compensatory down-regulation 
of endogenous mK8 (i.e., the conserved SAPK K8 S73 sub-
strate [S79 in mK8]) in response to mutant/WT hK8 overex-
pression (Fig. 1 B and Fig. 2 C), and (d) inhibition of K8 S73 
phosphorylation in K8 G61C. We tested this hypothesis by fi  rst 
showing that p42/44, JNK1/2, and p38 phosphorylation (and, 
hence, activation) were markedly but similarly increased in 
  response to Fas stimulation in WT and keratin mutant livers 
(Fig. 6 A), which supports previous reports that SAPKs play 
proapoptotic roles (Gallo and Johnson, 2002; Kaplowitz, 2002; 
  Baines and Molkentin, 2005). We then compared primary hepa-
tocyte cultures for their susceptibility to apoptosis by testing for 
the presence of caspase-generated products after Fas stimulation 
(Fig. 6 B). The use of primary hepatocyte cultures eliminates 
the potential variability among mice and makes it feasible to 
test multiple time points. Cleaved caspases 3/7 were detected 
between 3 and 5 h, but, as expected from the intact animal 
  studies (Fig. 2 C and Fig. 5 A), the cleaved caspase products 
were more evident in K8 G61C and S73A compared with WT 
hepatocytes (Fig. 6 B).
Finally, we compared the phosphorylation of endogenous 
mouse proteins that are known to serve as SAPK substrates: 
c-Jun (S63/S73) by JNK, cAMP response element binding protein 
(CREB) and NF-κB p65 by p38, and p90RSK by p42/44 
(Deak et al., 1998; Roux and Blenis, 2004; Liu and Lin, 2005). 
Although phosphorylation of NF-κB p65 was similar in K8 
WT, G61C, or S73A hepatocytes after Fas treatment, phosphor-
ylation of c-Jun, CREB, and p90RSK in K8 G61C and S73A 
hepatocytes was more pronounced and sustained when com-
pared with WT hepatocytes (Fig. 6 C). The pattern of phosphor-
ylated/activated SAPKs in K8 WT, G61C, or S73A hepatocytes 
after Fas treatment is relatively similar (Fig. 6 C), and activation 
by Fas is not as dramatic in primary cultures as it is in vivo 
(e.g., lanes 1 and 2 for phospho-JNK in Fig. 6 C, as contrasted 
with Fig. 6 A), which is likely caused by the stress incurred 
Figure 4.  K8 G61C mutation disrupts K8 S73 phos-
phorylation in vitro and in vivo. (A) Schematic of K8 
protein and its in vivo phosphorylation sites (Omary 
et al., 1998), and the distribution and frequency of K8 
mutations associated with human liver disease (Ku 
et al., 2005). The rod domain of all IF proteins is di-
vided into the following subdomains: IA, linker 1 (L1), 
IB, L12, and II. Positions of K8 phosphorylation (S23/
S73/S431) and the relevant kinases are shown. 
K8 variants are highlighted by arrowheads, with each 
arrowhead representing an independent patient from 
the 467 liver explants that were studied; the single 
large arrowhead for R340H indicates 30 individuals 
(Ku et al., 2005). I465-fs is a frame-shift mutation at 
Ile465 that generates a truncated 468–amino acid 
protein (instead of 482). (B) BHK cells were transiently 
cotransfected with K18 WT and one of the indicated 
K8 constructs, followed by immunoprecipitation of 
K8/K18, then in vitro phosphorylation by p38, JNK, 
or p42 kinases. Labeled immunoprecipitates (ip) were 
analyzed by SDS-PAGE and radiography. HK8 and 
K8 in the radiograph represent K8 S73 and K8 S431 
phosphorylation, respectively. Total lysates were also 
prepared from the transfected cells then blotted with 
Abs to the indicated epitopes. No band correspond-
ing to K8 S431 phosphorylation was detected in the 
pS431 immunoblot of K8 G433S (lane 6) because of 
an alteration of the Ab epitope in the mutant. (C) BHK 
cells were triple-transfected with K8/K18 WT or K8 
G61C/K18 WT, and WT or kinase-inactive p38 (AF 
mutant; T180A/Y182F). Total lysates were prepared 
and blotted with Ab to the indicated epitopes. Open 
arrows in B and C represent degraded K8.KERATINS AS A PHOSPHATE SPONGE • KU AND OMARY 121
upon hepatocyte isolation. Our data support the conclusion 
that increased phosphorylation of nonkeratin SAPK sub-
strates in G61C and S73A hepatocytes refl  ects a shunting of 
phosphorylation toward these other substrates in association 
with caspase activation.
Discussion
Disease relevance
The fi  ndings herein represent the fi  rst in vivo evidence that 
naturally occurring human K8 mutations can predispose to 
liver injury and apoptosis. Our results show that introducing 
hK8 G61C into mice predisposes to liver injury and apoptosis, 
and suggest the following sequence of events in response to 
stress: a G61C-mediated conformational change leads to the 
inability of K8 S73 to serve as a SAPK substrate, which creates 
an imbalance of kinase substrate availability, thereby predis-
posing to apoptosis and liver injury (Fig. 7). K8 G61C is the 
second most frequent liver disease–associated variant after 
R340H (Ku et al., 2005; Strnad et al., 2006a). Mutations of IF 
proteins, including keratins, desmin, neurofi  laments, and lam-
ins, among others, are associated with a wide range of tissue-
specifi  c human diseases (Fuchs and Cleveland, 1998; Omary 
et al., 2004). Compared with most other IF mutations, one 
unique characteristic of K8/K18 mutations is that they pose a 
risk of disease, rather than directly causing it (Omary et al., 
2002; Porter and Lane, 2003; Ku et al., 2005). The results 
herein fi  ll an important missing link by experimentally demon-
strating that a human disease-associated keratin mutation can, 
indeed, cause disease when an animal carrying the mutation is 
challenged by oxidative and other stresses. Therefore, the fi  nd-
ings in K8 G61C transgenic mice provide strong supporting 
evidence for the human association studies that have been per-
formed to date.
The mechanisms of liver injury predisposition by differ-
ent K8/K18 variants may be variant/disease-specifi  c or may 
have mechanistic overlap. This is supported by the inability 
of other (non-G61C) K8 natural mutants (e.g., G52V, Y53H, 
I465-fs [Fig. 4 B], and I62V [not depicted]) to interfere with 
SAPK phosphorylation of K8. Furthermore, K18 R89C (in 
mice) alters a K8/K18 mechanical function (i.e., fragility pre-
disposition) that is not shared by K8 G61C (Fig. 3 E). K18 
R89C also primes hepatocytes to undergo apoptosis (Ku et al., 
2003) and oxidative injury (Zhou et al., 2005), which are likely 
mechanisms that are shared by K8 G61C and K8 S73A. A com-
mon denominator for imparting protection from liver injury 
is keratin phosphorylation, which correlates with progression 
from chronic to end-stage liver disease (Toivola et al., 2004; 
  Zatloukal et al., 2004). This notion is supported by the fi  nd-
ing that K18 S52A (S52 is a major hK18 phosphorylation site) 
expression predisposes to hepatotoxic injury in transgenic mice 
(Ku et al., 1998), and by the results herein.
Figure 5.  hK8 S73A transgenic mice have increased susceptibility to Fas-mediated hepatocyte apoptosis and injury. (A) Livers from nontransgenic (lane 1) 
and the indicated transgenic lines (lanes 2–9) were isolated from control or Fas-injected (± Fas) mice and analyzed as described in Fig. 2 C. Two indepen-
dent transgenic lines per genotype (WT
1 and WT
2; S73A
1 and S73A
2) were used for the analysis (each of the lanes 2–9 represents one mouse from indi-
vidual transgenic lines). (B and C) Nontransgenic FVB/n, hK8 WT, or S73A mice (19–30 age- and sex-matched mice per genotype) were injected with 
Fas and monitored as described in Fig. 1. Most deaths occurred within 12 h after Fas injection. The results are summarized in C. Mortality was signiﬁ  cantly 
increased in hK8 S73A mice as compared with the combined (FVB/n + hK8 WT) mice. (D) Livers from Fas- or PBS-injected mice were analyzed by 
  immunoﬂ  uorescence staining (a–b’), by hematoxylin-eosin staining (c and c’), or TUNEL assay (d and d’). Hematoxylin-eosin staining and TUNEL assay 
of S73A livers under basal conditions (not depicted) were similar to those from the WT livers shown in Fig. 2 A (a and a’). H, hemorrhage. Bars: (a–b’) 
40 μm (c–d’) 160 μm.JCB • VOLUME 174 • NUMBER 1 • 2006  122
Relationship between K8 G61 mutation 
and S73 phosphorylation
The conformational link between K8 S73 phosphorylation and 
G61 is supported by the similar fi  ndings in K8 G61C and S73A 
mice, and by the inhibition of K8 S73 phosphorylation in vitro 
upon G61C mutation. This link is also supported by inhibition 
of binding of an Ab directed to a K8 G61C-containing epitope 
when S73 is phosphorylated (Tao et al., 2006). Immunoblotting 
of liver homogenates from transgenic mice with this Ab showed 
its binding with WT and S73A, but not with G61C K8 homogenates 
(Fig. S1, available at http://www.jcb.org/cgi/content/full/
jcb.200602146/DC1). K8 S73 phosphorylation also leads to a 
distinct retardation in migration during SDS-PAGE, which is 
specifi  c to that phosphorylation site and is also seen when S73 
is mutated to aspartate (Liao et al., 1997; Ku et al., 2002). 
Hence, the phenotype we observe appears to be caused by 
  mutation-related interference with a kinase–substrate interac-
tion though other direct/indirect interference with potential sta-
ble keratin and kinase–kinase regulator interactions is possible. 
For example, p38 and JNK associate with keratins, but this 
  association appears to be stoichiometrically limited and is more 
consistent with a kinase–substrate association (He et al., 2002; 
Figure 6.  Effect of K8 G61C or S73A mutation on SAPK activation and substrate phosphorylation. (A) Liver homogenates were obtained from the indicated 
transgenic mice (± Fas injection), separated by SDS-PAGE, and visualized by Coomassie staining (shown for equal loading) or by blotting with the indi-
cated Abs. (B) Hepatocytes were isolated by liver perfusion then treated with 0.5 μg/ml Fas Ab for the indicated times. Total cell lysates were then prepared 
and analyzed as in A. (top) Lanes 1–12 represent samples loaded on the same gel, whereas lanes 13–18 were loaded on a separate gel. (bottom) Repre-
sentative samples from the top panel that were analyzed on the same gel to conﬁ  rm the relative changes in caspase cleavage. (C) Total lysates of primary 
hepatocytes were prepared and analyzed as in B. Arrows likely represent degradation products. Note that phosphorylation of the SAPK substrates, c-Jun, 
CREB, and p90RSK, is increased and is more sustained in K8 G61C or S73A hepatocytes as compared with K8 WT hepatocytes.
Figure 7.  K8 mutation shunts keratin phosphorylation by 
stress-activated kinases. During stress, activated kinases 
such as p38 MAPK phosphorylate K8 S73 and other pro-
apoptotic substrates. However, K8 G61C mutation inter-
feres with the ability of the highly abundant K8 S73 to 
serve as a substrate, which renders other substrates avail-
able for potential phosphorylation and consequent rapid 
progression of apoptosis. Filled dots indicate phosphory-
lated residues. The phosphate sponge model works in a 
hepatocyte-protective fashion in livers that express WT K8 
and provides a function for K8 S73 phosphorylation that 
becomes unmasked upon K8 G61C mutation. This model 
predicts that keratins (and possibly other IFs) undergo hy-
perphosphorylation in part to absorb, in a “bulk” fashion 
given their abundance, cell kinase activation. Such sponge 
activity can be beneﬁ   cial (e.g., K8 S73), or potentially 
detrimental, in a phosphorylation site-speciﬁ  c and context-
dependent fashion. This model provides one (of several 
potential) nonmechanical functional capability for IFs and 
their phosphorylation and does not exclude the possibility 
that some kinase substrates may undergo dephosphoryla-
tion (e.g., via phosphatase activation by phosphorylation) 
and that other phosphorylation-dependent or -  independent 
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Ku et al., 2002). In addition, both WT and S73A K8 coimmuno-
precipitate with p38 MAPK, although we could not adequately 
test the K8 G61C mutant because of its limited solubility in 
mild detergents (unpublished data). Further support for a 
  conformational link between K8 G61C and S73 phosphoryla-
tion is that the G61C mutation inhibits in vitro phosphorylation 
of K8 S73 by purifi  ed SAPKs, but does not signifi  cantly affect 
K8 S431 phosphorylation (Fig. 4 B).
Lack of accessibility of SAPKs to K8 S73 upon G61C 
mutation may also be impacted by the formation of K8 cross-
links in response to oxidative stress (Ku et al., 2001; Owens 
et al., 2004). In this context, exposure to Fas or paraquat in-
creases K8 cross-linked species that are otherwise barely de-
tectable (Fig. 3 C). This refl  ects the change in the normally 
reducing cytoplasmic environment under stress, with produc-
tion of reactive oxygen species during Fas-mediated apoptosis 
and other oxidative stresses as seen in rat hepatocytes (Reinehr 
et al., 2005) and T cell lines (Sato et al., 2004). The effect of 
G61C on keratin solubility (Fig. 3, A and B) may also indepen-
dently contribute to kinase inaccessibility.
K8 S73 phosphorylation is likely to be associated with sev-
eral functions because it occurs during stress, apoptosis, and mitosis 
(Liao et al., 1997; Ku et al., 2002; Toivola et al., 2002). Previous 
studies in transfected cells (Ku et al., 2002) showed that K8 S73 
phosphorylation promotes keratin fi  lament reorganization (e.g., 
Ala substitution blocked stimulus-induced fi  lament reorganiza-
tion, which was rescued by Asp substitution). The multiplicity of 
keratin phosphorylation sites raises the untested possibility that 
site-specifi   c phosphorylation can have a domino effect that 
“opens” the fi  laments to additional phosphorylation/dephosphor-
ylation events, with consequent functional implications.
The phosphate sponge model
The similarity of the K8 G61C and S73A transgenic mice phe-
notypes supports an important role for S73 as a phosphate 
sponge for SAPKs in normal tissues undergoing stress. Amongst 
the earliest descriptions of IFs potentially serving as “phosphate 
sinks” was the observation of signifi  cant vimentin and keratin 
hyperphosphorylation after short exposure of cells to okadaic 
acid (Lai et al., 1993). Subsequent studies suggested that neuro-
fi  laments may serve as phosphate sinks (Nguyen et al., 2001), 
which was supported by others, although in this case the sink 
model is not protective, as initially hypothesized (Lobsiger 
et al., 2005). We elected to use the term “sponge” instead of sink 
because it is more general, in that sponges are more easily trans-
portable (i.e., dynamic) and not only collect spills but also allow 
their recovery (as free phosphates) with ready availability of 
fresh sponge capacity. We hypothesize that a phosphorylation 
sponge effect (Fig. 7) may be detrimental or benefi  cial, in a con-
text and phosphorylation site-specifi  c fashion, and that in the 
case of K8 S73 the phosphorylation role is benefi  cial. This 
model does not exclude the possibility that some antiapoptotic 
kinase substrates may in fact become hypophosphorylated, but 
predicts that overall phosphorylation is shunted, with the net 
  effect being enhanced apoptosis.
The abundance of cytoplasmic keratins allows for plenti-
ful sponge capacity. For example, K8/K18 can be easily seen by 
Coomassie staining upon HSE (Fig. 1 B), and they make up 5% 
of cultured colonocyte total proteins (Omary et al., 1998) and 
0.2% of total mouse liver protein (Zhong et al., 2004; the 0.2% 
is an underestimate because it includes proteins from other resi-
dent nonkeratin-containing endothelial and Kupffer cells and 
some blood proteins). Also, K8 S73 is a unique and readily 
available SAPK substrate because it behaves as a switch that is 
either “on” or “off,” being completely unphosphorylated (off) 
under basal conditions but turning on via phosphorylation dur-
ing apoptosis and cell injury (Liao et al., 1997).
SAPKs can play proapoptosis roles in several disorders, 
including liver (Kaplowitz, 2002), neuronal (Gallo and  Johnson, 
2002), and cardiac (Baines and Molkentin, 2005) disease. For 
example, disruption of JNK3 in mice results in resistance to 
  excitotoxicity-induced neuronal apoptosis (Yang et al., 1997) and 
pharmacologic inhibition of p38 interferes with TNF-induced 
hepatocyte apoptosis (Pastorino et al., 2003). Most of the 
known SAPK substrates are signaling molecules, such as pro-
tein   kinases (e.g., MSKs, RSKs, and MNKs), transcription fac-
tors (e.g., c-Jun, Elk-1, c-Fos, and NF-κB), or apoptosis-associated 
proteins (e.g., Bim and Bad; Roux and Blenis, 2004; Liu and 
Lin, 2005). Some protein kinases are phosphorylated and acti-
vated by SAPKs and then phosphorylate and activate transcrip-
tion factors among other substrates. For example, p38 MAPK 
phosphorylates MSK1 that can phosphorylate the CREB tran-
scription factor (Deak et al., 1998). The increased phosphoryla-
tion of cellular proteins after Fas stimulation was not universal 
in G61C and S73A hepatocytes (e.g., phospho–NF-κB p65 was 
not altered; Fig. 6 C). Several other substrates were tested, in-
cluding MSKs, Elk-1, c-Fos, c-Myc, p53, and Bim, but the re-
sults were unrevealing because of the lack of cross reactivity of 
the respective Abs with mouse proteins (unpublished data). The 
K8 G61C/S73A-associated increase in c-Jun phosphorylation 
supports the enhanced susceptibility of G61C and S73A hepa-
tocytes toward apoptosis, given that AP-1 members such as 
c-Jun are involved in proapoptotic or survival signaling depend-
ing on the cellular context and external stimulus. For example, 
stress-activated JNK phosphorylates c-Jun, which results in en-
hanced transcription of target genes (e.g., FasL) associated with 
apoptosis (Hess et al., 2004), and c-Jun S63/73 mutations in 
mice protects neurons from apoptosis (Behrens et al., 1999). 
The role of CREB and p90RSK is well studied in cell survival, 
but less so in proapoptotic pathways. However, serial analysis 
of chromatin occupancy supports the involvement of CREB in 
several proapoptotic gene products such as DEDD, TRADD, 
GADD45γ, and Bim (Impey et al., 2004).
Implications based on the relative 
conservation of K8 S73
Several type II keratins contain a unique LLS/TPL motif, which 
is 
71LLSPL in hK8 (i.e., S73-containing) or LLTPL in K4/K5/
K6 and hair keratins (Liao et al., 1997; Toivola et al., 2002). 
LLS/TPL is phosphorylated during apoptosis and other stresses 
by SAPKs in several epithelial tissues, including the liver and 
intestine (K8) and the esophagus and skin (K4/K5/K6; Liao 
et al., 1997; Ku et al., 2002; Toivola et al., 2002). Our fi  ndings 
suggest an important nonmechanical role for K8 in protecting JCB • VOLUME 174 • NUMBER 1 • 2006  124
hepatocytes from injury by serving as a phosphate sponge for 
SAPKs that can absorb some of their untoward effects (Fig. 7). 
This role may extend to keratins and their related diseases in 
other tissues where the K8 S73-containing LLS/TPL motif is 
conserved, and is negatively impacted by G61C mutation and 
possibly other K8 or K18 liver disease–associated mutations.
Materials and methods
Reagents and keratin-null mice
The reagents used include the following: MLR (Alexis Corp.), paraquat 
(Sigma-Aldrich), TdT-FragEL DNA fragmentation detection kit (Calbiochem), 
p38α MAPK (Upstate Biotechnology), JNK and p42 MAPK (Cell Signaling 
Technology), collagenase type II (Worthington Biochemical Corp.), and 
  Lipofectamine (Invitrogen). All Abs to keratins and phosphokeratins were 
previously described (Ku et al., 2004). Other Abs used were directed to Fas 
for mouse injection (BD Biosciences); to phospho- or nonphospho-p38, 
CREB, CREB pS133, p90RSK, phospho-p90RSK (human T359/S363 and 
mouse T348/S352), phospho-NF-κB p65 (human S536 and mouse S534), 
phospho-p42, JNK, and c-Jun (Cell Signaling Technology); to Fas for immuno-
blotting, FADD, and Bax (Upstate Biotechnology); and to Fas-ligand, 
  nonphospho–c-Jun (Santa Cruz Biotechnology, inc.). Two independent Abs 
were used to detect mouse c-Flip; one directed to an NH2-terminal region 
(S  A  E  V  I  H  Q  V  E  E  A  L  D  T  D  E  ) that is 100% identical in human and mouse c-Flip 
(Upstate Biotechnology), and another directed to a mouse-speciﬁ  c COOH-
terminal region (D  K  V  Y  A W  N  S  G  V  S  S  K  E  K  Y  S  ) of c-Flip (Sigma-Aldrich). K8- and 
K18-null mice were provided by R. Oshima (The Burnham Institute, La Jolla, 
CA) and T. Magin (University of Bonn, Bonn, Germany), respectively.
Transgene constructs and generation of transgenic lines
A transformer kit (CLONTECH Laboratories) was used to introduce single 
point mutations into a human (h) WT 12-kb genomic K8 clone (Krauss and 
Franke, 1990). The K8 genomic clone (provided by W. Franke, German 
Cancer Research Center, Heidelberg, Germany) includes endogenous reg-
ulatory elements that maintain tissue expression. Two mutant genomic con-
structs were generated (hK8 G61C or S73A), and both strands of the 
mutated region were sequenced to conﬁ  rm the mutation. Fidelity of the mu-
tant and WT constructs was veriﬁ  ed by testing its expression by transient 
transfection into BHK cells. The 12-kb Sal I fragments of mutant or WT ge-
nomic hK8 DNA were then injected into pronuclei of fertilized FVB/n 
mouse eggs. Progeny mice carrying the hK8 transgene were chosen after 
PCR screening of tail genomic DNA, which was followed by breeding to 
select for germline transmission (primers of a 250-bp PCR fragment; 
5′-G  G  C  G  G  C  G  G  C  T  A  T  G  G  T  G  G  G  G  C  C  -3′ and 5′-A  G  A  T  G  T  G  C  A  T  A  G  G  G  A-
C  C  G  G  G  A  -3′). Two independent heterozygous mouse lines per construct 
were established and expanded (K8: WT
1 and WT
2; G61C
1 and G61C
2; 
and S73A
1 and S73A
2), all in an FVB/n background, and then used for 
subsequent studies. The two transgenic lines for each construct had similar 
K8 expression and afforded near-identical results.
Toxin administration and hepatocyte isolation
For the lethality experiments, mice (age and sex matched) were fasted 
overnight, followed by intraperitoneal injection of Fas Ab (0.15 μg/g 
mouse body weight) or MLR (30 ng/g mouse body weight; Ku et al., 
2004). Mice were killed by CO2 inhalation 4 h after Fas Ab injection, and 
their livers were isolated and processed for immunoﬂ  uorescence, histology 
(HistoTec Laboratories), and TUNEL analyses (Ku et al., 2004). For induc-
tion of oxidative injury, mice were fasted overnight then injected intraperi-
toneally with paraquat (70 μg/g mouse body weight; Holzenberger et al., 
2003), followed by harvesting of livers after 60 h. Hepatocyte isolation 
was performed by liver perfusion of three to six age- and sex-matched 
mice/genotype, using collagenase type II (Ku et al., 1995). Cultured hepa-
tocytes were treated with Fas Ab (0.5 μg/ml for 0.5–5 h), followed by 
preparation of cell lysates for immunoblotting.
Biochemical and immunologic analyses
Keratins were isolated by HSE using liver pieces as previously described 
(Ku et al., 2004). Alternatively, total liver homogenates were prepared by 
solubilizing in SDS-containing buffer. Proteins were separated by SDS-
PAGE, followed by staining with Coomassie blue or transferal to mem-
branes; they were then immunoblotted and visualized by enhanced 
chemiluminescence. Quantitative immunoblotting was performed using 
  serial dilutions of the two samples to be compared and analyzed on the 
same gel. Immunoﬂ  uorescence staining was done as previously described 
(Ku et al., 2004), and ﬂ  uorescence images were analyzed using a confo-
cal microscope (MRC 1024ES; Bio-Rad Laboratories).
Solubility analysis and in vitro phosphorylation
BHK cells were transiently cotransfected (using Lipofectamine) with K18 WT 
and K8 (WT or mutant constructs; Ku et al., 2005) or K18 R89C and K8 
WT (Ku et al., 1995). 3 d after transfection, the cells were further cultured 
(37°C) in the presence or absence of 20 mM H2O2 for 1 h, followed by iso-
lation of a detergent-free, cytosolic soluble fraction or a total cell lysate (Ku 
et al., 2005). The triple transient transfections with kinase active/inactive 
p38α and keratins were also performed in BHK cells (Ku et al., 2002).
In vitro phosphorylation was done as previously described (Ku 
et al., 2004). K8/K18 immunoprecipitates, which were isolated from BHK-
transfected cells, were washed with kinase-speciﬁ  c buffers (Cell Signaling 
Technology; Upstate Biotechnology), heated (90°C) to inactivate any 
bound kinase activity, and incubated with the kinases (p38, JNK, or p42) 
and γ-[
32P]ATP (Ku et al., 2004). Kinase reactions were quenched by boil-
ing in the presence of 2% SDS-containing buffer, which was followed by 
analysis by SDS-PAGE and autoradiography.
Online supplemental material
Fig. S1 shows blotting with anti-hK8 G61C Ab that binds with WT and 
S73A, but not G61C K8, in transgenic liver homogenates. Online supple-
mental material is available at http://www.jcb.org/cgi/content/full/
jcb.200602146/DC1.
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